<SEC-DOCUMENT>0001178937-24-000037.txt : 20240730
<SEC-HEADER>0001178937-24-000037.hdr.sgml : 20240730
<ACCEPTANCE-DATETIME>20240730171541
ACCESSION NUMBER:		0001178937-24-000037
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20240730
DATE AS OF CHANGE:		20240730

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Tango Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001819133
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-39485
		FILM NUMBER:		241158828

	BUSINESS ADDRESS:	
		STREET 1:		201 BROOKLINE AVENUE
		STREET 2:		SUITE 901
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02215
		BUSINESS PHONE:		(857) 320-4900

	MAIL ADDRESS:	
		STREET 1:		201 BROOKLINE AVENUE
		STREET 2:		SUITE 901
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02215

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BCTG Acquisition Corp.
		DATE OF NAME CHANGE:	20200723

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Third Rock Ventures IV, L.P.
		CENTRAL INDEX KEY:			0001688327
		ORGANIZATION NAME:           	
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144

	BUSINESS ADDRESS:	
		STREET 1:		29 NEWBURY STREET, 3RD FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116
		BUSINESS PHONE:		617-585-2000

	MAIL ADDRESS:	
		STREET 1:		29 NEWBURY STREET, 3RD FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001688327</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001819133</issuerCik>
      <issuerName>Tango Therapeutics, Inc.</issuerName>
      <secFileNumber>001-39485</secFileNumber>
      <issuerAddress>
        <com:street1>201 BROOKLINE AVENUE</com:street1>
        <com:street2>SUITE 901</com:street2>
        <com:city>BOSTON</com:city>
        <com:stateOrCountry>MA</com:stateOrCountry>
        <com:zipCode>02215</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>(857) 320-4900</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Third Rock Ventures IV, L.P.</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Affiliate</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>BTIG, LLC</name>
        <address>
          <com:street1>350 Bush St.</com:street1>
          <com:street2>9th floor</com:street2>
          <com:city>San Francisco</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>94104</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>95000</noOfUnitsSold>
      <aggregateMarketValue>921500.00</aggregateMarketValue>
      <noOfUnitsOutstanding>106846262</noOfUnitsOutstanding>
      <approxSaleDate>07/30/2024</approxSaleDate>
      <securitiesExchangeName>NASD</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <acquiredDate>03/17/2017</acquiredDate>
      <natureOfAcquisitionTransaction>Pre-IPO</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Purchased from TRV III</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>95000</amountOfSecuritiesAcquired>
      <paymentDate>03/17/2017</paymentDate>
      <natureOfPayment>Wire</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Third Rock Ventures IV, L.P.</name>
        <address>
          <com:street1>201 Brookline Ave</com:street1>
          <com:street2>Suite 1401</com:street2>
          <com:city>Boston</com:city>
          <com:stateOrCountry>MA</com:stateOrCountry>
          <com:zipCode>02215</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <saleDate>07/17/2024</saleDate>
      <amountOfSecuritiesSold>550171</amountOfSecuritiesSold>
      <grossProceeds>5386339.14</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Third Rock Ventures IV, L.P.</name>
        <address>
          <com:street1>201 Brookline Ave</com:street1>
          <com:street2>Suite 1401</com:street2>
          <com:city>Boston</com:city>
          <com:stateOrCountry>MA</com:stateOrCountry>
          <com:zipCode>02215</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <saleDate>07/18/2024</saleDate>
      <amountOfSecuritiesSold>191490</amountOfSecuritiesSold>
      <grossProceeds>1878478.60</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Third Rock Ventures IV, L.P.</name>
        <address>
          <com:street1>201 Brookline Ave</com:street1>
          <com:street2>Suite 1401</com:street2>
          <com:city>Boston</com:city>
          <com:stateOrCountry>MA</com:stateOrCountry>
          <com:zipCode>02215</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <saleDate>07/22/2024</saleDate>
      <amountOfSecuritiesSold>262740</amountOfSecuritiesSold>
      <grossProceeds>2570096.41</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Third Rock Ventures IV, L.P.</name>
        <address>
          <com:street1>201 Brookline Ave</com:street1>
          <com:street2>Suite 1401</com:street2>
          <com:city>Boston</com:city>
          <com:stateOrCountry>MA</com:stateOrCountry>
          <com:zipCode>02215</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <saleDate>07/23/2024</saleDate>
      <amountOfSecuritiesSold>125000</amountOfSecuritiesSold>
      <grossProceeds>1223350.00</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Third Rock Ventures IV, L.P.</name>
        <address>
          <com:street1>201 Brookline Ave</com:street1>
          <com:street2>Suite 1401</com:street2>
          <com:city>Boston</com:city>
          <com:stateOrCountry>MA</com:stateOrCountry>
          <com:zipCode>02215</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <saleDate>07/24/2024</saleDate>
      <amountOfSecuritiesSold>200000</amountOfSecuritiesSold>
      <grossProceeds>1963160.00</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Third Rock Ventures IV, L.P.</name>
        <address>
          <com:street1>201 Brookline Ave</com:street1>
          <com:street2>Suite 1401</com:street2>
          <com:city>Boston</com:city>
          <com:stateOrCountry>MA</com:stateOrCountry>
          <com:zipCode>02215</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <saleDate>07/25/2024</saleDate>
      <amountOfSecuritiesSold>100599</amountOfSecuritiesSold>
      <grossProceeds>992771.29</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Third Rock Ventures IV, L.P.</name>
        <address>
          <com:street1>201 Brookline Ave </com:street1>
          <com:street2>Suite 1401</com:street2>
          <com:city>Boston</com:city>
          <com:stateOrCountry>MA</com:stateOrCountry>
          <com:zipCode>02215</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <saleDate>07/26/2024</saleDate>
      <amountOfSecuritiesSold>50000</amountOfSecuritiesSold>
      <grossProceeds>491950.00</grossProceeds>
    </securitiesSoldInPast3Months>
    <noticeSignature>
      <noticeDate>07/30/2024</noticeDate>
      <signature>Kevin Gillis</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
